Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$13.81 USD
+0.56 (4.23%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $13.80 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/8/24 |
---|---|
Current Quarter | 0.51 |
EPS Last Quarter | 1.00 |
Last EPS Surprise | 33.33% |
ABR | 1.60 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 2.37 |
Next Year | 2.61 |
EPS (TTM) | 2.56 |
P/E (F1) | 5.59 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.70B | 3.95B | 15.82B | 16.26B |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 3.80B | 4.04B | 16.04B | 16.50B |
Low Estimate | 3.61B | 3.83B | 15.72B | 15.89B |
Year ago Sales | 3.66B | 3.88B | 15.85B | 15.82B |
Year over Year Growth Est. | 1.06% | 1.79% | -0.13% | 2.74% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.51 | 0.58 | 2.37 | 2.61 |
# of Estimates | 7 | 6 | 7 | 7 |
Most Recent Consensus | NA | NA | NA | 2.48 |
High Estimate | 0.54 | 0.60 | 2.44 | 2.68 |
Low Estimate | 0.48 | 0.55 | 2.30 | 2.48 |
Year ago EPS | 0.40 | 0.56 | 2.56 | 2.37 |
Year over Year Growth Est. | 27.50% | 3.57% | -7.42% | 10.07% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 0 | 0 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.51 | 0.58 | 2.37 | 2.61 |
7 Days Ago | 0.51 | 0.58 | 2.37 | 2.61 |
30 Days Ago | 0.51 | 0.58 | 2.37 | 2.61 |
60 Days Ago | 0.51 | 0.58 | 2.37 | 2.62 |
90 Days Ago | 0.51 | 0.61 | 2.39 | 2.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.51 | 0.58 | 2.38 | 2.57 |
Zacks Consensus Estimate | 0.51 | 0.58 | 2.37 | 2.61 |
Earnings ESP | 0.00% | 0.00% | 0.42% | -1.67% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.00 | 0.60 | 0.56 | 0.40 | NA |
Estimate | 0.75 | 0.60 | 0.54 | 0.57 | NA |
Difference | 0.25 | 0.00 | 0.02 | -0.17 | 0.03 |
Surprise | 33.33% | 0.00% | 3.70% | -29.82% | 1.80% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more